| Model Number |
T505C21 |
| Medical Device Problem Code |
Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Calcium Deposits/Calcification (1758); Thrombosis/Thrombus (4440)
|
| Date of Event |
05/19/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that an unknown duration post implant of this 21mm hancock ii aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was not reported.Evidence of calcification seen in the left ventricular outflow tract (lvot) under the left coronary cusp (lcc).Calcification also seen in the proximal right coronary artery and in the sinotubular junction (stj) and ascending aorta.Protruding calcification and plaque/thrombus seen in descending thoracic aorta.No intervention or adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|